Oncolys BioPharma Inc. (4588.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 6,270.00

From 52W high−6.94%

Volume2.73M

Market capJPY 162.07B

P/E (TTM)—

P/S (TTM)322.2x

Div yield—

Key dataSep 18, 2026

Open

JPY 6,270.00

From 52W high

−6.94%

Volume

2.73M

Market cap

JPY 162.07B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−106.0x

P/E (TTM)

—

RSI (14)

75.2

MomentumView details →

1D Return

+8.62%

YTD Return

+389.16%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−106.0x

EV/Sales

317.4x

P/S (TTM)

322.2x

P/B (TTM)

49.8x

ProfitabilityView details →

Gross Margin

101.95%

Net Margin

−7350.00%

EBITDA Margin

−7227.71%

ROE (TTM)

−51.46%

ROA (TTM)

−45.18%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−9.68%

EPS YoY

−1.53%

FCF YoY

—

Revenue CAGR 3Y

−69.39%

EPS CAGR 3Y

−3.67%

EBITDA YoY

—

MomentumView details →

1D Return

+8.62%

YTD Return

+389.16%

1Y Return

+972.90%

RSI (14)

75.2

vs 50D SMA

+82.81%

vs 200D SMA

+161.71%

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

9.55x

Quick Ratio

9.55x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

31.55M

Net Income (TTM)

−1.66B

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

Japanese stocks rose on September 17, with Kubotek leading the Tokyo Stock Exchange Standard market gainers at a 29.6% increase.4d ago

Shares of Oncolys BioPharma fell 9.2% on September 16, 2026.5d ago

Similar companies

KISSEI PHARMACEUTICAL CO.,LTD.4547.T GNI Group Ltd.2160.T KAKEN PHARMACEUTICAL CO.,LTD.4521.T TOWA PHARMACEUTICAL CO.,LTD.4553.T SAWAI GROUP HOLDINGS Co.,Ltd.4887.T PeptiDream Inc.4587.T Find similar companies →

Latest newsMore news →

Japanese stocks rose on September 17, with Kubotek leading the Tokyo Stock Exchange Standard market gainers at a 29.6% increase.4d ago Shares of Oncolys BioPharma fell 9.2% on September 16, 2026.5d ago On September 1, 2026, four stocks hit limit-up and four hit limit-down at the close on the Tokyo Stock Exchange, including Brain's Technology, DeltaFly Pharma, Asterisk, and others.20d ago